Nicola Beltraminelli

Corporate Officer/Principal at INNATE PHARMA

56 year

Health Technology

Consumer Services

Commercial Services

Profile

Nicola Beltraminelli is currently the Director at Mabdesign Association and the Chief Development Officer & Vice President at Innate Pharma SA. Previously, he worked as the Chief Technical Officer at Lysogene SA. He holds a doctorate degree from the University of Lausanne.

Nicola Beltraminelli active positions

Companies	Position	Start
INNATE PHARMA	Corporate Officer/Principal	2021-12-31
Mabdesign Association Mabdesign Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization that aims to structure, mobilize and support in the field of therapeutic antibody & immunotherapy	Director/Board Member	-

All active positions of Nicola Beltraminelli

Former positions of Nicola Beltraminelli

Companies	Position	End
LYSOGENE	Chief Tech/Sci/R&D Officer	-

See the detail of Nicola Beltraminelli's experience

Training of Nicola Beltraminelli

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicola Beltraminelli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Innate Pharma SA Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes	Health Technology
University of Lausanne University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lysogene SA Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders	Health Technology
Mabdesign Association Mabdesign Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization that aims to structure, mobilize and support in the field of therapeutic antibody & immunotherapy	Commercial Services